Cited by 4Anesthesia and Sedative AgentsVeterinary Pharmacology and AnesthesiaAnesthesia and Pain Management

Efficacy and Safety of Remimazolam Tosilate Combined with Propofol in Digestive Endoscopy: A Randomised Trial

Open access
Cui, Liting, Shu, Kun, Zhang, Panpan, Cui, Qihao, Yun, Huifang·2023·Journal of Clinical Pharmacy and Therapeutics

Abstract

Current Knowledge and Objective. Remimazolam tosilate is a novel intravenous sedative of benzodiazepines with no tissue accumulation, which offers a faster onset of action and recovery time than midazolam. The aim of this trial was to compare the efficacy and safety of remimazolam (RM) combined with propofol and traditional propofol in painless digestive endoscopy with painless gastroscopy and colonoscopy. Methods. Patients were randomised into three groups: RM combined with propofol (RMP group, n = 35), RM (RM group, n = 40), and propofol (P group, n = 38). Each group received 0.1 μ g/kg sufentanyl analgesia. An induction dose of 0.1 mg/kg RM and 1 mg/kg propofol was administered to the RMP group, 0.3 mg/kg RM to the RM group, and 2 mg/kg propofol to the P group. Per 5 min, the RMP and RM groups received an additional dose of 0.05 mg/kg RM, while the P group received an extra 0.5 mg/kg propofol. The comparisons involved induction regimen success rate, incidence of hypotension, low pulse rate, injection pain, grade of low oxygen saturation (SpO 2), and postoperative adverse reactions. Results and Discussion. The RMP and P groups’ composition powers were 100%, and the RM group’s composition power was 95% (P = 0.113). The incidence rates of hypotension were 40.0%, 18.4%, and 44.7% in the RMP, RM, and P groups, respectively (P = 0.037). The low pulse incidence rates were 5.7%, 2.6%, and 5.3% in the RMP, RM, and P groups, respectively (P = 0.771). The incidence rates of injection pain were 11.4%, 2.6%, and 26.3% in the RMP, RM, and P groups, respectively (P = 0.007). There was no significant difference in low SpO 2 severity scores (P = 0.148). New Findings and Conclusion. Remimazolam tosilate combined with propofol can be used for painless endoscopy, with almost the same safety as propofol. Remimazolam tosilate produces a low incidence of adverse reactions and is a safe anaesthetic option for painless endoscopies.

Integrity signals

Registry

Crossref · 10.1155/2023/9955312

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cui, L., Shu, K., Zhang, P., Cui, Q., & Yun, H.
Affiliations
  • Changzhou No.2 People's Hospital (CN)
  • Dalian Medical University (CN)
  • Nanjing Medical University (CN)
Corresponding author
Yun, Huifang
Venue
Journal of Clinical Pharmacy and Therapeutics
Publisher
Wiley
Published
2023-01
Volume
2023
Issue
1
ISSN
  • 0269-4727 (ISSN-L)
  • 1365-2710
OpenAlex
W4366998722
Cited by
3
References
30
Citations by year
2025: 2 · 2024: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
Journal of Clinical Pharmacy and Therapeutics (publishedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
  • Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
Keywords
remimazolam tosilate, propofol, intravenous sedation, painless endoscopy, painless gastroscopy, painless colonoscopy, benzodiazepine sedation, hypotension, injection pain, oxygen saturation, sedation safety and efficacy, induction success rate, postoperative adverse reactions, recovery time, midazolam

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review